Abstract
Idiopathic recurrent pericarditis (IRP) is the most troublesome and common complication of acute pericarditis. The term “idiopathic” is used when infections (e.g., viruses or tuberculosis), neoplasms, and definite systemic diseases have been excluded. The diagnosis is based on the presence of typical symptoms and signs (pleuro-pericardial chest pain, pericardial rub, electrocardiographic alterations, pericardial effusion). Inflammatory markers and imaging techniques are confirmatory and help to manage the disease. Treatment includes the combination of nonsteroidal anti-inflammatory drugs (NSAIDs) at high dosage plus colchicine at low dosage; corticosteroids at medium-low dosages are often used, particularly in adult patients. In refractory cases, therapy with interleukin-1 inhibition has been remarkably effective.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AHA:
-
Anti-heart antibodies
- AIDA:
-
Anti-intercalated-disk antibodies
- AIRTRIP:
-
The Anakinra-Treatment of Recurrent Idiopathic Pericarditis
- ANAs:
-
Antinuclear antibodies
- AP-1:
-
Activator protein-1
- APC:
-
Antigen-presenting cell
- ASA:
-
Acetylsalicylic acid
- CEACAM1:
-
Carcinoembryonic antigen cell adhesion molecule 1
- CMR:
-
Cardiac magnetic resonance
- CMV:
-
Cytomegalovirus
- CRP:
-
C-reactive protein
- CT:
-
Computerized tomography
- DAMP:
-
Damage-associated molecular patterns
- EBV:
-
Epstein-Barr virus
- ECG:
-
Electrocardiogram
- ESC:
-
European Society of Cardiology
- ESR:
-
Erythrocyte sedimentation rate
- HCV:
-
Hepatitis C virus
- HIV:
-
Human immunodeficiency virus
- HLA:
-
Human leukocyte antigens
- HSV-1:
-
Herpes simplex virus
- IL:
-
Interleukin
- INF:
-
Interferonγ
- IRP:
-
Idiopathic recurrent pericarditis
- IVIg:
-
Intravenous immunoglobulins
- MHC:
-
Major histocompatibility complex
- MICA:
-
MHC class I chain-related protein A
- NF-kB:
-
Nuclear factor-kappa B
- NSAIDs:
-
Nonsteroidal anti-inflammatory drugs
- PAMP:
-
Pathogen-associated molecular patterns
- PPS:
-
Postpericardiotomy syndrome
- STIR:
-
Short-tau inverted recovery
- TLR:
-
Toll-like receptor
- TNF:
-
Tumor necrosis factor
- TRAPS:
-
TNF receptor–associated periodic fever syndrome
References
Maestroni S, Di Corato PR, Cumetti D, et al. Recurrent percarditis; autoimmune or autoinflammatory? Autoimmun Rev. 2012;12:60–5.
Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–64.
Finetti M, Insalaco A, Cantarini L, Meini A, Breda L, Alessio M, D’Alessandro M, Picco P, Martini A, Gattorno M. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014;164:1425–31.
Brucato A, Imazio M, Gattorno M, et al. Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence—The AIRTRIP Randomized Clinical Trial. JAMA. 2016;316:1906–12.
Kobberoe Sogard K, Farkas Kormendine D, Ehrenstein V, Bhaskaran K, Botker HE, Sorenson HT. Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation. 2017;136(11):996–1006. (Epub ahead of print).
Brucato A, Brambilla G. Recurrent idiopathic pericarditis: familial occurrence. Int J Cardiol. 2005;102:529.
Imazio M, Brucato A, Doria A, et al. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int J Cardiol. 2009;136:289–93.
Caforio AL, Brucato A, Doria A, et al. Anti-heart and anti-intercalated diskautoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96:779–84.
Lazaros G, Karavidas A, Spyropoulou M, et al. The role of the immunogenetic background in the development and recurrence of acute idiopathic pericarditis. Cardiology. 2011;118:55e62.
Hoffman M, Fried M, Jabareen F, et al. Anti-heart antibodies in postpericardiotomy syndrome: cause or epiphenomenon? A prospective, longitudinal pilot study. Autoimmunity. 2002;35:241–5.
Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011;97:1882–92.
Picco P, Brisca G, Martini A, et al. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra). Arthritis Rheum. 2009;60:264–8.
Rigante D, Cantarini L, Imazio M, et al. Autoinflammatory diseases and cardiovascular manifestations. Ann Med. 2011;43:341–6.
Cantarini L, Lucherini OM, Brucato A, et al. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol. 2012;101:525–31.
Xu B, Harb SC, Cremer PC. New insights into pericarditis: mechanisms of injury and therapeutic targets. Curr Cardiol Rep. 2017;19:60.
Brucato A, Emmi G, Cantarini L, Di Lenarda A, Gattorno M, Lopalco G, Marcolongo R, Imazio M, Martini A, Prisco D. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med. 2018;13(4):475–89. https://doi.org/10.1007/s11739-018-1842-x.
Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol. 2006;98:267–71.
Imazio M, Brucato A, Pluymaekers N, et al. Recurrent pericarditis in children and adolescents: a multicentre cohort study. J Cardiovasc Med (Hagerstown). 2016;17:707–12.
Raatikka M, Pelkonem PM, Karjalainen J, et al. Recurrent pericariditis in children and adolescents. J Am Coll Cardiol. 2003;42:759–64.
Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomized trial. Lancet. 2014;383:2232–7.
Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–8.
Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123:1092–7.
Markel G, Imazio M, Koren-Morag N, et al. CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis. Oncotarget. 2016;7:17885–95.
Cremer PC, Kumar A, Kontzias A, et al. Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment. J Am Coll Cardiol. 2016;68:2311–28.
Maggiolini S, De Carlini CC, Ferri LA, et al. The role of early contrast-enhanced chest computed tomography in the aetiological diagnosis of patients presenting with cardiac tamponade or large pericardial effusion. Eur Heart J Cardiovasc Imaging. 2016;17:421–8.
Vianello F, Cinetto F, Cavraro M, et al. Azathioprine in isolated recurrent pericarditis; a single centre experience. Int J Cardiol. 2011;147:477–8.
Kougkas N, Fanouriakis A, Papalopoulos I, Bertsias G, Avgoustidis N, Repa A, Sidiropoulos P. Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up. Rheumatology (Oxford). 2018;57(8):1494–5. https://doi.org/10.1093/rheumatology/key077.
Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124:1270–5.
Imazio M, Brucato A, Adler Y, et al. Prognosis of idiopathic recurrent pericarditisas determined from previously published reports. Am J Cardiol. 2007;100:1026–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Brucato, A., Valenti, A., Maestroni, S. (2020). Recurrent Pericarditis. In: Cimaz, R. (eds) Periodic and Non-Periodic Fevers. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-030-19055-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-19055-2_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19054-5
Online ISBN: 978-3-030-19055-2
eBook Packages: MedicineMedicine (R0)